American Portfolios Advisors Abb Vie Inc. Transaction History

American Portfolios Advisors

$2.36 Trillion
Q3 2022

A detailed history of American Portfolios Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 42,730 shares of ABBV stock, worth $7.69 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

42,730

Holding current value

$7.69 Million

% of portfolio

0.24%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 17, 2023	BUY	$134.21 - $153.93 $5.73 Million - $6.58 Million	42,730 New	42,730 $5.73 Billion
Q2 2022 Mar 20, 2023	SELL	$137.62 - $174.96 $743,836 - $945,658	-5,405 Reduced 12.65%	37,325 $5.72 Billion
Q1 2022 Mar 21, 2023	SELL	$131.98 - $163.75 $673,361 - $835,452	-5,102 Reduced 11.94%	37,628 $6.1 Billion
Q4 2021 Mar 21, 2023	SELL	$107.43 - $135.93 $927,765 - $1.17 Million	-8,636 Reduced 20.21%	34,094 $4.62 Billion
Q3 2021 Mar 22, 2023	SELL	$106.4 - $120.78 $1.54 Million - $1.75 Million	-14,459 Reduced 33.84%	28,271 $3.05 Billion
Q2 2021 Mar 22, 2023	SELL	$105.21 - $117.21 $1.81 Million - $2.01 Million	-17,178 Reduced 40.2%	25,552 $2.88 Billion
Q1 2021 Mar 22, 2023	SELL	$102.3 - $112.62 $2.09 Million - $2.3 Million	-20,406 Reduced 47.76%	22,324 $2.42 Billion
Q4 2020 Mar 22, 2023	SELL	$80.49 - $108.67 $1.86 Million - $2.51 Million	-23,120 Reduced 54.11%	19,610 $2.1 Billion
Q3 2020 Mar 22, 2023	SELL	$85.91 - $100.83 $2.03 Million - $2.38 Million	-23,614 Reduced 55.26%	19,116 $1.67 Billion
Q2 2020 Mar 24, 2023	BUY	$73.37 - $98.18 $653,800 - $874,881	8,911 Added 76.56%	20,550 $2.02 Billion
Q1 2020 Mar 24, 2023	SELL	$64.5 - $97.79 $2.01 Million - $3.04 Million	-31,091 Reduced 72.76%	11,639 $887 Million
Q4 2019 Mar 24, 2023	SELL	$72.13 - $90.25 $2.27 Million - $2.84 Million	-31,416 Reduced 73.52%	11,314 $1 Billion
Q3 2019 Mar 24, 2023	SELL	$62.98 - $75.72 $291,660 - $350,659	-4,631 Reduced 33.57%	9,163 $694 Million
Q2 2019 Mar 24, 2023	SELL	$65.7 - $83.98 $1.9 Million - $2.43 Million	-28,936 Reduced 67.72%	13,794 $1 Billion
Q1 2019 Mar 24, 2023	SELL	$77.14 - $90.79 $30,084 - $35,408	-390 Reduced 2.95%	12,825 $1.03 Billion
Q4 2018 Mar 24, 2023	SELL	$77.85 - $96.01 $210,272 - $259,323	-2,701 Reduced 16.97%	13,215 $1.22 Billion
Q3 2018 Mar 24, 2023	SELL	$88.91 - $98.84 $2.38 Million - $2.65 Million	-26,814 Reduced 62.75%	15,916 $1.51 Billion
Q2 2018 Mar 24, 2023	BUY	$89.78 - $106.23 $25,587 - $30,275	285 Added 1.81%	16,065 $1.49 Billion
Q1 2018 Mar 24, 2023	SELL	$92.01 - $123.21 $2.48 Million - $3.32 Million	-26,950 Reduced 63.07%	15,780 $1.49 Billion
Q4 2017 Mar 24, 2023	SELL	$89.56 - $98.21 $1.67 Million - $1.83 Million	-18,660	24,070 $2.33 Billion

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

News

Stay updated on American Portfolios Advisors with notifications on news.

Account

American Portfolios Advisors Abb Vie Inc. Transaction History